Insights

Panel Discussion on Life Sciences Transactions, Research Collaborations, and Licensing Models to be presented on June 17, 2017

San Diego, CA- May 31, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as a panel member and address legal professionals at the 5th Annual World Life Sciences Conference, June 16–17, 2017 at the Westin San Diego Gaslamp Quarter, San Diego, CA. The conference is presented by the International Bar Association (IBA), a global voice for the legal profession. The event will feature dynamic roundtable sessions covering the hottest topics and the latest developments from across the different sectors of the Life Science Industry.

(more…)

• Tweet

Life Sciences, OCP News

San Diego, CA, May 15, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, has announced that it has been retained as exclusive advisor to Global Health Solutions, LLC, to assist the company in exploring strategic partnerships and licensing agreements for its diverse product portfolio and pipeline for wound care, infection, and skin care. The priority focus will be on seeking best in class commercialization partners for the Company’s 510K FDA-cleared Hexagen™ Wound Dressing, which addresses the pressing need for effective solutions in the chronic and advanced wound market(s).  Additional assets to be partnered include the FiltreX™ Adhesive Dressing and pipeline assets in dermatology, infection control, biologics, and aesthetics.

(more…)

• Tweet

Healthcare, Life Sciences, OCP News, Buy-Side M&A, Strategic Advisory

San Diego, CA, May 9, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, has been announced as a finalist for Boutique Investment Banking Firm of the Year as part of the 9^th Annual International M&A Advisor Awards. The M&A Advisor also recognized Objective Capital Partners as finalists in categories for Consumer Discretionary Deal of the Year and Corporate Strategic Deal of the Year ($100mm-250mm).  This is the third year in a row that Objective Capital Partners has been nominated by The M&A Advisor as an award finalist.

(more…)

• Tweet

Awards